Menu
Membership
FASEB
Volunteer Login
Search
Science Policy and Advocacy
Science Policy and Advocacy
Federal Research Funding Data
Recommended Research Funding
NSF Matters
Become an Advocate
Federal Harassment Policies and Resources
Meetings and Events
Meetings and Events
Events
Science Research Conferences
FASEB Conferences On-Demand
Catalyst Conferences
Webinars
Sponsorships
Organize an Event
Professional Development
Professional Development
FASEB Fellows for the Future
FASEB MOSAIC
FASEB Science Policy Fellowship
Howard Garrison Advocacy Fellowship
Resources
Resources
Animals in Research and Education
One Health
Scientific Workforce
Shared Research Resources
Journals and News
Journals and News
The FASEB Journal
FASEB BioAdvances
Latest News
Washington Update
Data Management and Sharing
Data Management and Sharing
DataWorks! Help Desk
DataWorks! Prize
DataWorks! Salon
Awards
Awards
BioArt Awards
CARES Awards
Public Service Award
Excellence in Science Awards
FASEB Journal Early Career Researcher Awards
Member Society Fellowships
Diversity, Equity, and Inclusion
Diversity, Equity, and Inclusion
LEAD
Partnerships and Outreach
Partnerships and Outreach
Legislative Action Center
Membership Information
Search
Contact Us
Latest News
Home
Journals and News
Latest News
The FASEB Journal: New Strategy to Reduce Cancer Drug's Cardiotoxic Effects
The FASEB Journal: New Strategy to Reduce Cancer Drug's Cardiotoxic Effects
Thursday, April 11, 2019